1. Efficacy of neratinib in the treatment of HER2/neu-amplified epithelial ovarian carcinoma in vitro and in vivo
    Gulden Menderes et al, 2017, Med Oncol CrossRef
  2. SPR platform based on image acquisition for HER2 antigen detection
    Johny P Monteiro et al, 2017, Nanotechnology CrossRef
  3. Methods and significance of the combined detection of HER2 gene amplification and chemosensitivity in gastric cancer
    Yang-Kun Wang et al, 2017, CBM CrossRef
  4. Specific antibodies and sensitive immunoassays for the human epidermal growth factor receptors (HER2, HER3, and HER4)
    Marianne Nordlund Broughton et al, 2017, Tumour Biol. CrossRef
  5. The role of extracellular and intracellular nicotinamide phosphoribosyl-transferase in cancer: diagnostic and therapeutic perspectives and challenges
    Maria Dalamaga et al, 2018, Metabolism CrossRef
  6. Autophagy in ischemic stroke
    Pei Wang et al, 2018, Progress in Neurobiology CrossRef
  7. Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells
    Zahra Hesari et al, 2018, Gene CrossRef
  8. Effects of RNA interference-mediated silencing of toll-like receptor 4 gene on proliferation and apoptosis of human breast cancer MCF-7 and MDA-MB-231 cells: An in vitro study
    Xiao-Ling Gao et al, 2018, J Cell Physiol CrossRef
  9. NAD Metabolism in Cancer Therapeutics
    Keisuke Yaku et al, 2018, Front. Oncol. CrossRef
  10. Identification of specific pre-analytical quality control markers in plasma and serum samples
    Luz Ruiz-Godoy et al, 2019, Anal. Methods CrossRef
  11. NAD+ salvage pathway in cancer metabolism and therapy
    Barry E. Kennedy et al, 2016, Pharmacological Research CrossRef
  12. Extracellular NAMPT/Visfatin induces proliferation through ERK1/2 and AKT and inhibits apoptosis in breast cancer cells
    Zafar Gholinejad et al, 2017, Peptides CrossRef
  13. Prognostic value of visfatin in various human malignancies: A systematic review and meta-analysis
    Masoumeh Mohammadi et al, 2020, Cytokine CrossRef
  14. Beyond Energy Metabolism: Exploiting the Additional Roles of NAMPT for Cancer Therapy
    Christine M. Heske, 2020, Front. Oncol. CrossRef
  15. The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5)
    Simone Torretta et al, 2020, Cells CrossRef
  16. Therapeutic Strategies and Biomarkers to Modulate PARP Activity for Targeted Cancer Therapy
    Naveen Singh et al, 2020, Cancers CrossRef
  17. Overexpression of collagen type V α1 chain in human breast invasive ductal carcinoma is mediated by TGF-β1.
    Weimin Ren et al, 0 CrossRef
  18. Comprehensive analysis of marker gene detection and computed tomography for the diagnosis of human lung cancer
    Min Cheng et al, 2018, Oncol Lett CrossRef
  19. Adipocytokines visfatin and resistin in breast cancer: Clinical relevance, biological mechanisms, and therapeutic potential
    Yen-Yun Wang et al, 2020, Cancer Letters CrossRef
  20. Advances in NAD-Lowering Agents for Cancer Treatment
    Moustafa S. Ghanem et al, 2021, Nutrients CrossRef